TI
LENZ

Trexquant Investment’s LENZ Therapeutics LENZ Stock Holding History

Trexquant Investment’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.83M Buy
497,526
+283,118
+132% +$2.28M 0.02% 1035
2026
Q1 		$1.96M Buy
214,408
+41,225
+24% +$579K 0.01% 1006
2025
Q4 		$2.77M Buy
+173,183
New +$5.05M 0.02% 860

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Trexquant Investment's LENZ Position: Q2 2026 in Review

Trexquant Investment increased its LENZ Therapeutics (LENZ) stake by 132% in Q2 2026, buying an estimated $2.28M and bringing the position to 497,526 shares worth $2.83M. The position accounts for 0.02% of the portfolio, ranked #1035.

Trexquant Investment first reported a position in LENZ in Q4 2025 and has held it in 3 quarters since. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Trexquant Investment held 497,526 shares of LENZ Therapeutics worth $2.83M as of Q2 2026.
  • Trexquant Investment bought 283,118 LENZ Therapeutics shares in Q2 2026, an estimated $2.28M.
  • LENZ Therapeutics made up 0.02% of Trexquant Investment's portfolio in Q2 2026, its #1035 holding.
  • Trexquant Investment first reported a position in LENZ Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.